j.hartmann
TL2 Moderator · Oulu
Contributes reviews on supplier material. Based in Oulu.
Joined 4 February 2025 · last posted 4d
80 posts, newest first. Showing up to 150.
-
What a certificate commits its issuer to Replied, post #91 · Analytics › COA interpretation · 24 Jul 2026 · 19 likes Picking up post #88: that is the part I would want checked first. A certificate of analysis is a statement by its issuer that a defined test was performed on a defined…
-
Osteoarthritis and mechanical versus metabolic improvement Replied, post #6 · Clinical › Comorbidities · 17 Jul 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
When your prescriber and the evidence disagree Replied, post #18 · Clinical › Prescriber conversations · 16 Jul 2026 · 0 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
-
Insurance and replacement policies, compared Replied, post #77 · Sourcing › Logistics · 10 Jul 2026 · 0 likes Worth separating two things that post #73 runs together. Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain…
-
Coming back to: Batch date after test date, and other internal inconsistencies Replied, post #8 · Analytics › COA interpretation · 9 Jul 2026 · 30 likes Worth separating two things that post #4 runs together. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #33 · Pharmacology › Pharmacokinetics · 24 Jun 2026 · 23 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Gastro-oesophageal reflux: improving or worsening? Replied, post #57 · Clinical › Comorbidities · 19 Jun 2026 · 21 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #39 · Compounds › Secretagogues & GH axis · 17 Jun 2026 · 0 likes Coming back to post #37, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Revisiting: The best-written scientific paper you have read Replied, post #36 · Lounge › Off topic · 17 Jun 2026 · 13 likes post #35 is right about the mechanism and I think understates the practical bit. Politics and public policy: healthcare policy that affects access to these compounds is…
-
Aggregate verification data across the directory, with caveats Started this topic · Sourcing › Independent verification · 15 Jun 2026 · 47 likes On the subject in the title: Aggregate verification data across the directory, with caveats Working notes rather than a conclusion. Structured report rather than an…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #24 · Practice › Administration · 15 Jun 2026 · 18 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Prescription portability between countries Replied, post #61 · Access › International · 11 Jun 2026 · 0 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks.
-
Racemisation and why it is invisible to a mass measurement Replied, post #10 · Analytics › Impurities & related substances · 8 Jun 2026 · 8 likes Worth separating two things that post #6 runs together. Oxidation at methionine and tryptophan: adds 16 per oxygen. Usually elutes earlier. Oxidation is common in…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #5 · Pharmacology › Pharmacokinetics · 30 May 2026 · 22 likes This follows post #2 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #36 · Analytics › Home & field testing · 29 May 2026 · 0 likes Colorimetric tests: colour intensity correlates with concentration, but the relationship is non-linear at extremes and the correlation depends on the exact conditions…
-
Why the timeline is on the right and not the left — what changed since Replied, post #40 · Meta › Site feedback · 21 May 2026 · 1 like Coming back to post #38, because the follow-up matters more than the original answer. Performance: if pages are slow to load, timeouts occur, or the site is…
-
Blind submission and why it changes minds — the long version Replied, post #81 · Sourcing › Independent verification · 17 May 2026 · 2 likes post #80 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Five questions in one post gets you one answer — how to split them Replied, post #80 · Start Here › How to Ask · 13 May 2026 · 0 likes Picking up post #77: that is the part I would want checked first. Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #15 · Analytics › Impurities & related substances · 10 May 2026 · 19 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #3 · Clinical › Special populations · 8 May 2026 · 32 likes Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
-
Blind submission and why it changes minds — the long version Replied, post #62 · Sourcing › Independent verification · 7 May 2026 · 13 likes I read post #60 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #105 · Practice › Reconstitution · 24 Apr 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #29 · Practice › Interactions · 20 Apr 2026 · 30 likes Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this drug class already does that. The conservative position during titration…
-
Grapefruit: why this class is not the class that cares Replied, post #134 · Practice › Interactions · 8 Apr 2026 · 0 likes Food interactions: most interactions are absorption interactions. Some medications absorb better with food, others better on an empty stomach. With an incretin agonist…
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #28 · Data & Tools › Calculators · 5 Apr 2026 · 10 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
Journal club: is percentage weight change the right endpoint? Replied, post #21 · Evidence › Journal club · 28 Mar 2026 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Coming back to: Why a preprint's supplementary material is often the best part Replied, post #12 · Evidence › Preprints · 16 Mar 2026 · 0 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #152 · Sourcing › Independent verification · 7 Mar 2026 · 3 likes This follows post #149 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it…
-
What "marked as solution" means and who gets to mark it — does this still hold? Replied, post #50 · Start Here › Welcome · 6 Mar 2026 · 5 likes Introducing yourself is fine and requires no question. Post in this subcategory, describe the context that matters for why you are here, and lurk for a bit before…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #87 · Evidence › Study critique · 25 Feb 2026 · 18 likes Worth separating two things that post #83 runs together. Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #69 · Practice › Dosing & titration · 18 Feb 2026 · 0 likes Reaching a dose and staying there for a year: the question of whether a stable dose remains effective over years is mostly answered by the withdrawal trials and by…
-
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #49 · Practice › Interactions · 9 Feb 2026 · 2 likes post #48 is right about the mechanism and I think understates the practical bit. Oral medications versus time: if you take an oral medication 30 minutes before…
-
The most common factual error about semaglutide on the internet — what changed since Replied, post #17 · Compounds › Semaglutide · 31 Jan 2026 · 3 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #63 · Sourcing › Vendor reports · 29 Jan 2026 · 4 likes Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and identity. PeptideMeter gives verification records as well as…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #70 · Clinical › Special populations · 24 Jan 2026 · 0 likes Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially…
-
Muscle cramps: the ordinary causes before the exotic ones Started this topic · Practice › Side effects · 11 Jan 2026 · 4 likes Muscle cramps: the ordinary causes before the exotic ones Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the…
-
Revisiting: Absolute versus relative contraindications Replied, post #5 · Safety › Contraindications · 8 Jan 2026 · 12 likes Medullary thyroid carcinoma (personal or family history) or multiple endocrine neoplasia type 2: absolute contraindication. The rodent preclinical signal is real enough…
-
The headache that turns out to be dehydration Replied, post #106 · Nutrition & Training › Hydration & electrolytes · 23 Dec 2025 · 4 likes Potassium: similar to sodium; losing weight involves some potassium loss. Bananas, sweet potatoes, and other potassium-rich foods help. Severe depletion is rare but…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #100 · Compounds › Oral incretins · 19 Dec 2025 · 0 likes Dose numbers for oral formulations are not comparable to injectable ones. The 14 mg oral dose is not equivalent to any injectable dose in the traditional comparison…
-
DXA precision and the least significant change for lean mass Replied, post #53 · Outcomes › Body composition · 8 Dec 2025 · 11 likes On post #49 — agreed on the reasoning, with one qualification. Bioelectric impedance analysis: less precise than DXA and strongly affected by hydration state. Not…
-
A plateau that disappeared when I changed how I measured Started this topic · Outcomes › Progress reports · 3 Dec 2025 · 31 likes Posting this under the heading it deserves: A plateau that disappeared when I changed how I measured Everything below is what sits behind that. Longitudinal report with…
-
Reading SURMOUNT-1 without the press release Replied, post #84 · Compounds › Tirzepatide · 30 Nov 2025 · 29 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
When to stop reading forums, including this one Replied, post #53 · Wellbeing › Mental health · 24 Nov 2025 · 0 likes Disordered eating history: a history of anorexia, bulimia, or other eating disorders changes the risk-benefit calculation. Appetite suppression might trigger relapse.…
-
Cross-border purchase rules within the EU Replied, post #43 · Regional › European Union · 23 Nov 2025 · 0 likes post #42 answers the question as asked. The question underneath it is different. France: ANSM implements EU framework. Reimbursement has been narrower for weight…
-
Reading SURMOUNT-1 without the press release Replied, post #65 · Compounds › Tirzepatide · 13 Nov 2025 · 5 likes Picking up post #62: that is the part I would want checked first. The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #85 · Sourcing › Vendor reports · 4 Nov 2025 · 7 likes Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a consistent pattern becomes a record worth discussing. Two…
-
Long-time reader, first-time poster Replied, post #4 · Lounge › Introductions · 3 Nov 2025 · 4 likes Worth separating two things that post #2 runs together. Welcome: the response to introductions is usually welcome. People will reply to introduce themselves back or to…
-
Availability by country, dated, with primary sources Replied, post #42 · Access › International · 1 Nov 2025 · 19 likes Coming back to post #40, because the follow-up matters more than the original answer. Currency and exchange rates: paying in different currencies has different costs…
-
New subcategory: rationale and scope Replied, post #102 · Meta › Announcements · 23 Oct 2025 · 0 likes Notifications: watching this subcategory means you receive notifications when announcements are posted. Useful if you want to stay current.
-
Second pass at: Programming during a large energy deficit Replied, post #51 · Nutrition & Training › Resistance training · 23 Oct 2025 · 10 likes Intensity: using weights that allow 6 to 12 reps before fatigue is a reasonable range for preserving muscle. Heavier weights with lower reps can work but require more…
-
Tirzepatide and nausea: is the profile genuinely different or just differently reported? Replied, post #15 · Compounds › Tirzepatide · 22 Oct 2025 · 3 likes On post #11 — agreed on the reasoning, with one qualification. The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose.…
-
Payment mechanics and the recovery options that do not exist Replied, post #43 · Sourcing › Payments · 20 Oct 2025 · 12 likes On post #39 — agreed on the reasoning, with one qualification. Recurring billing: if a supplier sets up recurring billing by default, understanding the terms for…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #90 · Devices › Cold chain · 15 Oct 2025 · 17 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #2 · Clinical › Bloodwork · 13 Oct 2025 · 1 like Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #76 · Compounds › Cagrilintide & amylin analogues · 4 Oct 2025 · 28 likes Worth separating two things that post #72 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #87 · Practice › Administration · 30 Sep 2025 · 0 likes Worth separating two things that post #83 runs together. Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal is ordinary. Whether you lost…
-
Substitution between formats during a shortage Replied, post #65 · Access › Shortages · 28 Sep 2025 · 14 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
-
Follow-up: Sodium, potassium and magnesium when intake drops Replied, post #5 · Nutrition & Training › Hydration & electrolytes · 25 Sep 2025 · 13 likes Sodium: losing weight involves losing some sodium. Electrolyte drinks or salty foods help maintain sodium balance. Very low sodium intake on these compounds raises…
-
Personal import allowances, compared — a second dataset Replied, post #2 · Access › International · 20 Sep 2025 · 0 likes Regulatory position dates: a regulatory position is only current as of when it was written. Rechecking is prudent, especially if you saw it months ago.
-
Research-use-only labelling: what it means and what it does not Replied, post #35 · Sourcing › Regulatory · 18 Sep 2025 · 26 likes On post #31 — agreed on the reasoning, with one qualification. Regulatory positions change: a compound's status today might differ from its status a year from now.…
-
Titles that describe the question, not the situation — what changed since Replied, post #24 · Start Here › How to Ask · 18 Sep 2025 · 29 likes Worth separating two things that post #20 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
Enforcement priorities versus written rules — does this still hold? Replied, post #41 · Sourcing › Regulatory · 1 Sep 2025 · 0 likes Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that is not on the market under specific conditions. The conditions are strict…
-
Are there stupid questions here? A staff answer, at length Replied, post #104 · Start Here › Welcome · 23 Aug 2025 · 27 likes I read post #102 twice before replying, because I had assumed the opposite. The moderation log is public. Every staff action is logged with the rule cited and the…
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #36 · Compounds › Secretagogues & GH axis · 4 Aug 2025 · 22 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
An emergency department visit, described afterwards Replied, post #49 · Safety › Adverse events · 2 Aug 2025 · 0 likes Allergic reactions: true allergy (anaphylaxis, severe rash) is rare with these peptide compounds but possible. Distinguishing true allergy from GI intolerance matters.
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #76 · Compounds › Semaglutide · 19 Jul 2025 · 2 likes I read post #74 twice before replying, because I had assumed the opposite. The mass figure differs between sources because of how the different entities report it. The…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Started this topic · Sourcing › Vendor reports · 12 Jul 2025 · 54 likes Second pass at: What "verified" means on our vendor pages, stated narrowly — setting out what I have, and where I think it stops being reliable. A logistics question,…
-
Repeatability versus intermediate precision Replied, post #10 · Analytics › Method validation · 18 Jun 2025 · 25 likes Picking up post #7: that is the part I would want checked first. Range: the concentration range over which the method has been validated. Going outside the validated…
-
Pre-registering a personal experiment, seriously Replied, post #67 · Research Methods › N-of-1 designs · 31 May 2025 · 0 likes Sample size in n-of-1: you are the sample. Repeated measurements (weekly weighings, daily mood scores) increase the power to detect a real effect even though n=1.
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #21 · Devices › Syringes & needles · 20 May 2025 · 0 likes Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm (standard), or 10-12 mm (longer). Longer needles are needed for deeper tissue or if…
-
Deamidation and the close-eluting pair it produces Replied, post #9 · Analytics › Impurities & related substances · 14 Mar 2025 · 28 likes Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide. Affects mass calculations and should be stated on a complete…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #4 · Access › Insurance & coverage · 6 Mar 2025 · 0 likes On post #3 — agreed on the reasoning, with one qualification. Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes…
-
What a seizure notice actually says Replied, post #32 · Sourcing › Logistics · 10 Feb 2025 · 29 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
-
Canadian access and provincial variation Replied, post #54 · Regional › North America · 4 Feb 2025 · 6 likes Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access barriers. The denial letter tells you which barrier…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #32 · Evidence › Journal club · 23 Dec 2024 · 13 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: When to suspect the method rather than the sample Replied, post #45 · Analytics › Method validation · 8 Dec 2024 · 0 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Time to steady state after a dose increase Replied, post #128 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 9 likes Picking up post #125: that is the part I would want checked first. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability.…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #134 · Clinical › Bloodwork · 22 Oct 2024 · 0 likes post #133 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Correlation in a self-tracked dataset: what it can support Replied, post #45 · Research Methods › Statistics · 22 Aug 2024 · 26 likes Absence of evidence and evidence of absence: if a study is small and finds no effect, that is absence of evidence, not evidence of absence. A larger study might find an…
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #23 · Analytics › COA interpretation · 9 Aug 2024 · 7 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…